Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice

Journal of Clinical Investigation

Volumn 118, Issue 2, 2008, Pages 571-582

  Li, Tianfu ^a   Ren, Gaoying ^a   Lusardi, Theresa ^a   Wilz, Andrew ^a   Lan, Jing Q ^a   Iwasato, Takuji ^b   Itohara, Shigeyoshi ^b   Simon, Roger P ^a   Boison, Detlev ^a  

^a LEGACY RESEARCH   (United States)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE KINASE; CYCLOSPORIN A; LORAZEPAM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN INJURY; BRAIN REGION; CELL TRANSPLANTATION; DRUG TARGETING; ELECTROENCEPHALOGRAM; EPILEPSY; EPILEPTOGENESIS; FOCAL EPILEPSY; FOREBRAIN; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEIZURE; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE;

ADENOSINE KINASE; ANIMALS; ASTROCYTES; BRAIN; EPILEPSIES, PARTIAL; KAINIC ACID; MALE; MICE; MICE, TRANSGENIC; PROGNOSIS; SEIZURES;

EID: 38849100495     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI33737     Document Type: Article

References (46)

1. Pitkanen, A., and Sutula, T.P. 2002. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol. 1:173-181.
2. Haydon, P.G., and Carmignoto, G. 2006. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol. Rev. 86:1009-1031.
3. Tian, G.F., et al. 2005. An astrocytic basis of epilepsy. Nat. Med. 11:973-981.
4. Arabadzisz, D., Antal, K., Parpan, F., Emri, Z., and Fritschy, J.M. 2005. Epileptogenesis and chronic seizures in a mouse model of temporal lobe epilepsy are associated with distinct EEG patterns and selective neurochemical alterations in the contralateral hippocampus. Exp. Neurol. 194:76-90.
5. Shinoda, S., et al. 2004. Bim regulation may determine hippocampal vulnerability after injurious seizures and in temporal lobe epilepsy. J. Clin. Invest. 113:1059-1068.
6. Shetty, A.K., Zaman, V., and Hattiangady, B. 2005. Repair of the injured adult hippocampus through graft-mediated modulation of the plasticity of the dentate gyrus in a rat model of temporal lobe epilepsy. J. Neurosci. 25:8391-8401.
7. Fredholm, B.B., Chen, J.F., Cunha, R.A., Svenningsson, P., and Vaugeois, J.M. 2005. Adenosine and brain function. Int. Rev. Neurobiol. 63:191-270.
8. Johansson, B., et al. 2001. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc. Natl. Acad. Sci. U. S. A. 98:9407-9412.
9. Huber, A., et al. 2001. Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proc. Natl. Acad. Sci. U. S. A. 98:7611-7616.
10. Etherington, L.A., and Frenguelli, B.G. 2004. Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype-dependent manner. Eur. J. Neurosci. 19:2539-2550.
11. Dunwiddie, T.V. 1999. Adenosine and suppression of seizures. Adv. Neurol. 79:1001-1010.
12. Dunwiddie, T.V. 1980. Endogenously released adenosine regulates excitability in the in vitro hippocampus. Epilepsia. 21:541-548.
13. Dragunow, M., Goddard, G.V., and Laverty, R. 1985. Is adenosine an endogenous anticonvulsant? Epilepsia. 26:480-487.
14. Lee, K.S., Schubert, P., and Heinemann, U. 1984. The anticonvulsive action of adenosine: a postsynaptic, dendritic action by a possible endogenous anticonvulsant. Brain Res. 321:160-164.
15. During, M.J., and Spencer, D.D. 1992. Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Ann. Neurol. 32:618-624.
16. Boison, D. 2006. Adenosine kinase, epilepsy and stroke: mechanisms and therapies. Trends Pharmacol. Sci. 27:652-658.
17. Studer, F.E., et al. 2006. Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme. Neuroscience. 142:125-137.
18. Gouder, N., Scheurer, L., Fritschy, J.-M., and Boison, D. 2004. Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J. Neurosci. 24:692-701.
19. Fedele, D.E., et al. 2005. Astrogliosis in epilepsy leads to overexpression of adenosine kinase resulting in seizure aggravation. Brain. 128:2383-2395.
20. Pignataro, G., Simon, R.P., and Boison, D. 2007. Transgenic overexpression of adenosine kinase aggravates cell death in ischemia. J. Cereb. Blood Flow Metab. 27:1-5.
21. Boison, D. 2005. Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. Neuroscientist. 11:25-36.
22. Boison, D. 2007. Adenosine-based cell therapy approaches for pharmacoresistant epilepsies. Neurodegener. Dis. 4:28-33.
23. Li, T., et al. 2007. Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants. Brain. 130:1276-1288.
24. Araki, T., Simon, R.P., Taki, W., Lan, J.Q., and Henshall, D.C. 2002. Characterization of neuronal death induced by focally evoked limbic seizures in the C57BL/6 mouse. J. Neurosci. Res. 69:614-621.
25. Iwasato, T., et al. 2004. Dorsal telencephalon-specific expression of Cre recombinase in PAC transgenic mice. Genesis. 38:130-138.
26. Boison, D., et al. 2002. Neonatal hepatic steatosis by disruption of the adenosine kinase gene. Proc. Natl. Acad. Sci. U. S. A. 99:6985-6990.
27. Fedele, D.E., et al. 2004. Engineering embryonic stem cell derived glia for adenosine delivery. Neurosci. Lett. 370:160-165.
28. Tashiro, A., Goldberg, J., and Yuste, R. 2002. Calcium oscillations in neocortical astrocytes under epileptiform conditions. J. Neurobiol. 50:45-55.
29. Duffy, S., and MacVicar, B.A. 1999. Modulation of neuronal excitability by astrocytes. Adv. Neurol. 79:573-581.
30. Rebola, N., et al. 2005. Long-term effect of convulsive behavior on the density of adenosine A1 and A 2A receptors in the rat cerebral cortex. Epilepsia. 46(Suppl. 5):159-165.
31. Glass, M., et al. 1996. Loss of A1 adenosine receptors in human temporal lobe epilepsy. Brain Res. 710:56-68.
32. Rebola, N., et al. 2003. Decrease of adenosine A1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats. Eur. J. Neurosci. 18:820-828.
33. 2 to cortical excitability via pH. Neuron. 48:1011-1023.
34. Fedele, D.E., Li, T., Lan, J.Q., Fredholm, B.B., and Boison, D. 2006. Adenosine A1 receptors are crucial in keeping an epileptic focus localized. Exp. Neurol. 200:184-190.
35. Kochanek, P.M., et al. 2006. Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury. J. Cereb. Blood Flow Metab. 26:565-575.
36. Riban, V., et al. 2002. Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy. Neuroscience. 112:101-111.
37. Arch, J.R., and Newsholme, E.A. 1978. Activities and some properties of 5?-nucleotidase, adenosine kinase and adenosine deaminase in tissues from vertebrates and invertebrates in relation to the control of the concentration and the physiological role of adenosine. Biochem. J. 174:965-977.
38. Bontemps, F., Van den Berghe, G., and Hers, H.G. 1983. Evidence for a substrate cycle between AMP and adenosine in isolated hepatocytes. Proc. Natl. Acad. Sci. U. S. A. 80:2829-2833.
39. Bontemps, F., Vincent, M.F., and Van den Berge, G. 1993. Mechanisms of elevation of adenosine levels in anoxic hepatocytes. Biochem. J. 290:671-677.
40. Delaney, S.M., and Geiger, J.D. 1996. Brain regional levels of adenosine and adenosine nucleotides in rats killed by high-energy focused microwave irradiation. J. Neurosci. Methods. 64:151-156.
41. Yee, B.K., Singer, P., Chen, J.F., Feldon, J., and Boison, D. 2007. Transgenic overexpression of adenosine kinase in brain leads to multiple learning impairments and altered sensitivity to psychomimetic drugs. Eur. J. Neurosci. 26:3237-3252.
42. Ren, G., et al. 2007. Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control. Exp. Neurol. 208:26-37.
43. Kowaluk, E.A., and Jarvis, M.F. 2000. Therapeutic potential of adenosine kinase inhibitors. Expert Opin. Investig. Drugs. 9:551-564.
44. McGaraughty, S., Cowart, M., Jarvis, M.F., and Berman, R.F. 2005. Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitors. Curr. Top. Med. Chem. 5:43-58.
45. McGaraughty, S., and Jarvis, M.F. 2006. Purinergic control of neuropathic pain. Drug Dev. Res. 67:376-388.
46. Okabe, S., Forsberg-Nilsson, K., Spiro, A.C., Segal, M., and McKay, R.D. 1996. Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro. Mech. Dev. 59:89-102.